Synergy Pharmaceuticals Inc fka SGYPQ

[chemist99]

Frontiers, as an epilogue to your nicely written post, thought I'd add that the USPTO reexamination of the crucial Ironwood method of use patent requested by SGYP in 2012 has just been brought to a favorable conclusion, --- for IRWD, that is...

(track down via control no. 95001990 in the public PAIR system at the USPTO website)

June 26, 2012 US PATENT AND TRADEMARK OFFICE Print This Notice 1379 OG 224

Requests for Inter Partes Reexamination Filed
Requests for Inter Partes Reexamination Filed

7,704,947, Reexam. C.N.: 95/001,990, Requested Date: May 15, 2012, Cl.:
514/002, Title: METHODS AND COMPOSITIONS FOR THE TREATMENT OF
GASTROINTESTINAL DISORDERS, Inventor: Mark G. Currie et al., Owners of
Record: Ironwood Pharmaceuticals, Inc., Cambridge, MA, Attorney or Agent:
Honigman Miller Schwartz & Cohn, LLP, Kalamazoo, MI, Ex. Gp.: 3991,
Requester: Third Party Requester: Synergy Pharmaceuticals, Inc.; (Att'y
Is: Ivor R. Elrifi, Mintz Levin Cohn Ferris Glovsky & Popeo, PC., Boston,
MA), Real Party in Interest: Same As Third Party Requester

http://portal.uspto.gov/pair/view/BrowsePdfServlet?objectId=HJ8PF8AGPXXIFW4&lang=DINO